Inflammation: the next target for secondary prevention in coronary artery disease

Med J Aust. 2024 Feb 19;220(3):115-120. doi: 10.5694/mja2.52209. Epub 2024 Jan 21.

Authors

Samia Kazi^{1

2}, James J H Chong^{2

3}, Clara K Chow^{2

3}

Affiliations

¹ Westmead Applied Research Centre, University of Sydney, Sydney, NSW.
² Westmead Hospital, Sydney, NSW.
³ University of Sydney, Sydney, NSW.

PMID: 38246595
DOI: 10.5694/mja2.52209

No abstract available

Keywords: Anti-inflammatory agents; Coronary artery disease; Inflammation; Risk factors.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Coronary Artery Disease* / prevention & control
Humans
Inflammation / drug therapy
Secondary Prevention

Substances

Anti-Inflammatory Agents